BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 15155785)

  • 1. Transrepression of estrogen receptor beta signaling by nuclear factor-kappab in ovarian granulosa cells.
    Chu S; Nishi Y; Yanase T; Nawata H; Fuller PJ
    Mol Endocrinol; 2004 Aug; 18(8):1919-28. PubMed ID: 15155785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estradiol promotes cell survival and induces Greb1 expression in granulosa cell tumors of the ovary through an ERα-dependent mechanism.
    Cluzet V; Devillers MM; Petit F; Pierre A; Giton F; Airaud E; L'Hôte D; Leary A; Genestie C; Treilleux I; Mayeur A; Katzenellenbogen JA; Kim SH; Cohen-Tannoudji J; Chauvin S; Guigon CJ
    J Pathol; 2022 Mar; 256(3):335-348. PubMed ID: 34860414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and role of estrogen receptor alpha and beta in medullary thyroid carcinoma: different roles in cancer growth and apoptosis.
    Cho MA; Lee MK; Nam KH; Chung WY; Park CS; Lee JH; Noh T; Yang WI; Rhee Y; Lim SK; Lee HC; Lee EJ
    J Endocrinol; 2007 Nov; 195(2):255-63. PubMed ID: 17951536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positive feedback activation of estrogen receptors by the CXCL12-CXCR4 pathway.
    Sauvé K; Lepage J; Sanchez M; Heveker N; Tremblay A
    Cancer Res; 2009 Jul; 69(14):5793-800. PubMed ID: 19584281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oestrogen receptors pathways to oestrogen responsive elements: the transactivation function-1 acts as the keystone of oestrogen receptor (ER)beta-mediated transcriptional repression of ERalpha.
    Gougelet A; Mueller SO; Korach KS; Renoir JM
    J Steroid Biochem Mol Biol; 2007 May; 104(3-5):110-22. PubMed ID: 17478088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Negative regulation of estrogen signaling by ERβ and RIP140 in ovarian cancer cells.
    Docquier A; Garcia A; Savatier J; Boulahtouf A; Bonnet S; Bellet V; Busson M; Margeat E; Jalaguier S; Royer C; Balaguer P; Cavaillès V
    Mol Endocrinol; 2013 Sep; 27(9):1429-41. PubMed ID: 23885094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen receptor alpha and beta subtype expression and transactivation capacity are differentially affected by receptor-, hsp90- and immunophilin-ligands in human breast cancer cells.
    Gougelet A; Bouclier C; Marsaud V; Maillard S; Mueller SO; Korach KS; Renoir JM
    J Steroid Biochem Mol Biol; 2005 Feb; 94(1-3):71-81. PubMed ID: 15862952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
    Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
    Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 4-hydroxytamoxifen trans-represses nuclear factor-kappa B activity in human osteoblastic U2-OS cells through estrogen receptor (ER)alpha, and not through ER beta.
    Quaedackers ME; Van Den Brink CE; Wissink S; Schreurs RH; Gustafsson JA; Van Der Saag PT; Van Der Burg BB
    Endocrinology; 2001 Mar; 142(3):1156-66. PubMed ID: 11181531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ganoderma lucidum inhibits proliferation of human breast cancer cells by down-regulation of estrogen receptor and NF-kappaB signaling.
    Jiang J; Slivova V; Sliva D
    Int J Oncol; 2006 Sep; 29(3):695-703. PubMed ID: 16865287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression by estrogen receptor beta of AP-1 mediated transactivation through estrogen receptor alpha.
    Maruyama S; Fujimoto N; Asano K; Ito A
    J Steroid Biochem Mol Biol; 2001 Aug; 78(2):177-84. PubMed ID: 11566442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The classical and a non-classical pathways associated with NF-kappaB are involved in estrogen-mediated regulation of calbindin-D9k gene in rat pituitary cells.
    Lee GS; Choi KC; Han HJ; Jeung EB
    Mol Cell Endocrinol; 2007 Oct; 277(1-2):42-50. PubMed ID: 17825480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome-wide mapping of estrogen receptor-beta-binding regions reveals extensive cross-talk with transcription factor activator protein-1.
    Zhao C; Gao H; Liu Y; Papoutsi Z; Jaffrey S; Gustafsson JA; Dahlman-Wright K
    Cancer Res; 2010 Jun; 70(12):5174-83. PubMed ID: 20501845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determining the transrepression activity of xenoestrogen on nuclear factor-kappa B in Cos-1 cells by estrogen receptor-alpha.
    Ansari RA; Gandy J
    Int J Toxicol; 2007; 26(5):441-9. PubMed ID: 17963131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding of estrogen receptor beta to estrogen response element in situ is independent of estradiol and impaired by its amino terminus.
    Huang J; Li X; Maguire CA; Hilf R; Bambara RA; Muyan M
    Mol Endocrinol; 2005 Nov; 19(11):2696-712. PubMed ID: 15976006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitors of both nuclear factor-kappaB and activator protein-1 activation block the neoplastic transformation response.
    Li JJ; Westergaard C; Ghosh P; Colburn NH
    Cancer Res; 1997 Aug; 57(16):3569-76. PubMed ID: 9270030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
    Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
    Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen receptor (ER)-mediated transcriptional regulation of the human corticotropin-releasing hormone-binding protein promoter: differential effects of ERalpha and ERbeta.
    van de Stolpe A; Slycke AJ; Reinders MO; Zomer AW; Goodenough S; Behl C; Seasholtz AF; van der Saag PT
    Mol Endocrinol; 2004 Dec; 18(12):2908-23. PubMed ID: 15345745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen receptor (ER) beta modulates ERalpha-mediated transcriptional activation by altering the recruitment of c-Fos and c-Jun to estrogen-responsive promoters.
    Matthews J; Wihlén B; Tujague M; Wan J; Ström A; Gustafsson JA
    Mol Endocrinol; 2006 Mar; 20(3):534-43. PubMed ID: 16293641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen receptor-alpha mediates gene expression changes and growth response in ovarian cancer cells exposed to estrogen.
    O'Donnell AJ; Macleod KG; Burns DJ; Smyth JF; Langdon SP
    Endocr Relat Cancer; 2005 Dec; 12(4):851-66. PubMed ID: 16322326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.